Log in to save to my catalogue

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disea...

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85c3ec866a7b4d63a0ce9bb218832267

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review

About this item

Full title

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2020-11, Vol.12 (1), p.141-141, Article 141

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Possession of the ε4 allele of apolipoprotein E (APOE) is the primary genetic risk factor for the sporadic form of Alzheimer's disease (AD). While researchers have extensively characterized the impact that APOE ε4 (APOE4) has on the susceptibility of AD, far fewer studies have investigated the phenotypic differences of patients with AD who are APOE...

Alternative Titles

Full title

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85c3ec866a7b4d63a0ce9bb218832267

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85c3ec866a7b4d63a0ce9bb218832267

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-020-00712-4

How to access this item